A case of pyoderma gangrenosum induced by insulin

Malcom Noronha, Sukriti Arora, Kantilatha Pai, B. Sathish Pai, Anuradha Jindal

Research output: Contribution to journalArticle

Abstract

Pyoderma gangrenosum (PG) is a rare auto-inflammatory, neutrophilic, ulcerative disorder characterised by acutely painful, rapidly spreading, sterile ulcers over the trunk and lower limbs. The pathogenic mechansim of PG is under constant evolution and drugs are emerging to be a an important trigger. In the literature, 52 cases of drug-induced PG have been documented, of which cocaine laced with levamisole has shown most direct association, with a mean Naranjo score of 9. Other drugs probably associated with PG are isotretinoin, sunitinib, and propylthiouracil. We describe a case of a 59-year-old male who had multiple well-defined ulcers with a violaceous, undermined edge limited to the site of subcutaneous injection of insulin. Histopathological examination showed psoriasiform hyperplasia in the epidermis, with abundant infiltration of neutrophils in the dermis, consistent with the clinical diagnosis of PG. As per the modified Naranjo algorithm, the patient's total score was 7, indicating insulin to be the probable causative agent in our case. So, compiling temporal localisation of lesions to the site of administration of insulin and clinical, histopathological, and Naranjo score evidence all prompt the diagnosis of PG. Insulin stimulates the release of matrix-metalloproteinases 9 which acts as endopeptidases and also results in the chemotaxis of neutrophils, causing ulcer formation. This is the first case reporting PG triggered by insulin.

Original languageEnglish
Pages (from-to)1239-1242
Number of pages4
JournalInternational Wound Journal
Volume16
Issue number5
DOIs
Publication statusPublished - 01-10-2019

Fingerprint

Pyoderma Gangrenosum
Insulin
Ulcer
Pharmaceutical Preparations
Propylthiouracil
Isotretinoin
Endopeptidases
Levamisole
Neutrophil Infiltration
Matrix Metalloproteinase 9
Chemotaxis
Subcutaneous Injections
Dermis
Cocaine
Epidermis
Hyperplasia
Lower Extremity
Neutrophils

All Science Journal Classification (ASJC) codes

  • Surgery
  • Dermatology

Cite this

Noronha, M., Arora, S., Pai, K., Sathish Pai, B., & Jindal, A. (2019). A case of pyoderma gangrenosum induced by insulin. International Wound Journal, 16(5), 1239-1242. https://doi.org/10.1111/iwj.13170
Noronha, Malcom ; Arora, Sukriti ; Pai, Kantilatha ; Sathish Pai, B. ; Jindal, Anuradha. / A case of pyoderma gangrenosum induced by insulin. In: International Wound Journal. 2019 ; Vol. 16, No. 5. pp. 1239-1242.
@article{bd70572bcc594bd2818ca1c5023c8f0f,
title = "A case of pyoderma gangrenosum induced by insulin",
abstract = "Pyoderma gangrenosum (PG) is a rare auto-inflammatory, neutrophilic, ulcerative disorder characterised by acutely painful, rapidly spreading, sterile ulcers over the trunk and lower limbs. The pathogenic mechansim of PG is under constant evolution and drugs are emerging to be a an important trigger. In the literature, 52 cases of drug-induced PG have been documented, of which cocaine laced with levamisole has shown most direct association, with a mean Naranjo score of 9. Other drugs probably associated with PG are isotretinoin, sunitinib, and propylthiouracil. We describe a case of a 59-year-old male who had multiple well-defined ulcers with a violaceous, undermined edge limited to the site of subcutaneous injection of insulin. Histopathological examination showed psoriasiform hyperplasia in the epidermis, with abundant infiltration of neutrophils in the dermis, consistent with the clinical diagnosis of PG. As per the modified Naranjo algorithm, the patient's total score was 7, indicating insulin to be the probable causative agent in our case. So, compiling temporal localisation of lesions to the site of administration of insulin and clinical, histopathological, and Naranjo score evidence all prompt the diagnosis of PG. Insulin stimulates the release of matrix-metalloproteinases 9 which acts as endopeptidases and also results in the chemotaxis of neutrophils, causing ulcer formation. This is the first case reporting PG triggered by insulin.",
author = "Malcom Noronha and Sukriti Arora and Kantilatha Pai and {Sathish Pai}, B. and Anuradha Jindal",
year = "2019",
month = "10",
day = "1",
doi = "10.1111/iwj.13170",
language = "English",
volume = "16",
pages = "1239--1242",
journal = "International Wound Journal",
issn = "1742-4801",
publisher = "Wiley-Blackwell",
number = "5",

}

Noronha, M, Arora, S, Pai, K, Sathish Pai, B & Jindal, A 2019, 'A case of pyoderma gangrenosum induced by insulin', International Wound Journal, vol. 16, no. 5, pp. 1239-1242. https://doi.org/10.1111/iwj.13170

A case of pyoderma gangrenosum induced by insulin. / Noronha, Malcom; Arora, Sukriti; Pai, Kantilatha; Sathish Pai, B.; Jindal, Anuradha.

In: International Wound Journal, Vol. 16, No. 5, 01.10.2019, p. 1239-1242.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A case of pyoderma gangrenosum induced by insulin

AU - Noronha, Malcom

AU - Arora, Sukriti

AU - Pai, Kantilatha

AU - Sathish Pai, B.

AU - Jindal, Anuradha

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Pyoderma gangrenosum (PG) is a rare auto-inflammatory, neutrophilic, ulcerative disorder characterised by acutely painful, rapidly spreading, sterile ulcers over the trunk and lower limbs. The pathogenic mechansim of PG is under constant evolution and drugs are emerging to be a an important trigger. In the literature, 52 cases of drug-induced PG have been documented, of which cocaine laced with levamisole has shown most direct association, with a mean Naranjo score of 9. Other drugs probably associated with PG are isotretinoin, sunitinib, and propylthiouracil. We describe a case of a 59-year-old male who had multiple well-defined ulcers with a violaceous, undermined edge limited to the site of subcutaneous injection of insulin. Histopathological examination showed psoriasiform hyperplasia in the epidermis, with abundant infiltration of neutrophils in the dermis, consistent with the clinical diagnosis of PG. As per the modified Naranjo algorithm, the patient's total score was 7, indicating insulin to be the probable causative agent in our case. So, compiling temporal localisation of lesions to the site of administration of insulin and clinical, histopathological, and Naranjo score evidence all prompt the diagnosis of PG. Insulin stimulates the release of matrix-metalloproteinases 9 which acts as endopeptidases and also results in the chemotaxis of neutrophils, causing ulcer formation. This is the first case reporting PG triggered by insulin.

AB - Pyoderma gangrenosum (PG) is a rare auto-inflammatory, neutrophilic, ulcerative disorder characterised by acutely painful, rapidly spreading, sterile ulcers over the trunk and lower limbs. The pathogenic mechansim of PG is under constant evolution and drugs are emerging to be a an important trigger. In the literature, 52 cases of drug-induced PG have been documented, of which cocaine laced with levamisole has shown most direct association, with a mean Naranjo score of 9. Other drugs probably associated with PG are isotretinoin, sunitinib, and propylthiouracil. We describe a case of a 59-year-old male who had multiple well-defined ulcers with a violaceous, undermined edge limited to the site of subcutaneous injection of insulin. Histopathological examination showed psoriasiform hyperplasia in the epidermis, with abundant infiltration of neutrophils in the dermis, consistent with the clinical diagnosis of PG. As per the modified Naranjo algorithm, the patient's total score was 7, indicating insulin to be the probable causative agent in our case. So, compiling temporal localisation of lesions to the site of administration of insulin and clinical, histopathological, and Naranjo score evidence all prompt the diagnosis of PG. Insulin stimulates the release of matrix-metalloproteinases 9 which acts as endopeptidases and also results in the chemotaxis of neutrophils, causing ulcer formation. This is the first case reporting PG triggered by insulin.

UR - http://www.scopus.com/inward/record.url?scp=85070276773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070276773&partnerID=8YFLogxK

U2 - 10.1111/iwj.13170

DO - 10.1111/iwj.13170

M3 - Article

C2 - 31353778

AN - SCOPUS:85070276773

VL - 16

SP - 1239

EP - 1242

JO - International Wound Journal

JF - International Wound Journal

SN - 1742-4801

IS - 5

ER -